US Patent Issued to Nykode Therapeutics ASA on July 28 for "Individualized therapeutic anticancer vaccine" (Norwegian Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,165, issued on July 28, was assigned to Nykode Therapeutics ASA (Oslo, Norway).

"Individualized therapeutic anticancer vaccine" was invented by Agnete Brunsvik Fredriksen (Raelingen, Norway), Monika Sekelja (Oslo, Norway), Karoline Schjetne (Lommedalen, Norway) and Stine Granum (Oslo, Norway).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an individualized therapeutic anticancer vaccine, methods of treatment of cancer wherein such an anticancer vaccine is used as well as methods for producing the vaccine."

The patent was filed on April 9, 2021, under Application No. 17/995,780.

*For further information, including im...